在瘤扩张中的空间突变差异
Haiyang Li1,2, Zixuan Yang1, Fengyu Tu1
1Group of Theoretical Biology, The State Key Laboratory of Bio-control, School of Life Sciences, Sun Yat-sen University, Guangzhou 510275, People's Republic of China.
Journal of the Royal Society, Interface
|November 21, 2023
概括
瘤内部异质性 (ITH) 随着采样距离的增加而增加,影响药物耐药性. 突变率推断在快速生长的瘤中是可靠的,但在较小的样本大小或缓慢的瘤扩张时变得不准确.
科学领域:
- 在瘤学瘤学.
- 计算生物学 计算生物学
- 遗传学 是一个遗传学.
背景情况:
- 瘤内部异质性 (ITH) 源于瘤进化过程中的突变积累,经常导致药物耐药性.
- 多区域测序研究突出突变差异和空间采样对于全面瘤分析的必要性.
- 关联突变异质与瘤扩张模式,采样距离和方法的定量数据仍然有限.
研究的目的:
- 调查空间采样距离和瘤扩张模式如何影响突变分歧.
- 量化瘤内部异质性,采样策略和推断突变率之间的关系.
- 为了比较不同瘤生长模型和样本大小的突变率推断精度.
主要方法:
- 利用基于个体的模拟来模拟瘤演变,采用不同的采样距离和扩张模式.
- 在模拟样本之间使用Jaccard指数量化瘤内部异质性.
- 分析了变异性等位基因频率分布,以在不同的模拟参数下推断突变率.
主要成果:
- 瘤内部异质性随着采样距离的增加而增加,无论采样方法或大小如何.
- 在指数级扩张的瘤中可以推断出突变率,但在较小的样本大小下,准确性会下降.
- 在缓慢生长的瘤中,对突变率的推断变得不可靠,例如那些表现出表面生长的瘤.
结论:
- 空间采样距离是影响瘤内异质性的关键因素.
- 精确的突变率推断取决于瘤扩张动态和适当的样本大小.
- 模拟模型为推动瘤进化和异质性的因素的复杂相互作用提供了宝贵的见解.
相关概念视频
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Cancers Originate from Somatic Mutations in a Single Cell
12.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
Mismatch Repair
4.9K
Organisms are capable of detecting and fixing nucleotide mismatches that occur during DNA replication. This sophisticated process requires identifying the new strand and replacing the erroneous bases with correct nucleotides. Mismatch repair is coordinated by many proteins in both prokaryotes and eukaryotes.
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
The Mutator Protein Family Plays a Key Role in DNA Mismatch Repair
The human genome has more than 3 billion base pairs of DNA per cell. Prior to cell division, that vast amount of genetic...
4.9K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Cancer
48.6K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.6K
Cancer Stem Cells and Tumor Maintenance
4.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
4.9K


